Drugs Affecting Neurotransmitter Synthesis
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Human Genetics
Modeling in Therapy
Attention-Deficit/Hyperactivity Disorder
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 10, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Nora D Volkow1, Gene-Jack Wang, Scott H Kollins
1National Institute on Drug Abuse, 6001 Executive Blvd, Room 5274, MSC 9581, Bethesda, MD 20892, USA. nvolkow@nida.nih.gov
Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) exhibit reduced dopamine synaptic markers in the brain's reward pathway. These dopamine transporter and receptor reductions correlate with inattention symptoms, suggesting a biological basis for reward-motivation deficits in ADHD.
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: